Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona Lalloo

Showing results (21-30 of 162) with videos related to

Pageof 17
Sort By:
Familial Cancer|July 20, 2007
BRCA1/2 mutation analysis in male breast cancer families from North West EnglandD G R Evans, Mike Bulman, Karen Young, et al.
Lancet (London, England)|April 4, 2003
Prediction of pathogenic mutations in patients with early-onset breast cancer by family historyFiona Lalloo, Jennifer Varley, David Ellis, et al.
Journal of Medical Genetics|February 25, 2012
Life expectancy in hereditary cancer predisposing diseases: an observational studyAnna Wilding, Sarah Louise Ingham, Fiona Lalloo, et al.
Journal of Medical Genetics|March 9, 2023
<i>MSH2</i> is the very young onset ovarian cancer predisposition gene, not <i>BRCA1</i>Nicola Flaum, Emma J Crosbie, Emma Roisin Woodward, et al.
BMC Medical Informatics and Decision Making|October 3, 2014
Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?Mattia C F Prosperi, Sarah L Ingham, Anthony Howell, et al.
Familial Cancer|March 13, 2024
Cascade screening in HBOC and Lynch syndrome: guidelines and procedures in a UK centreD Gareth Evans, Kate Green, George J Burghel, et al.
European Journal of Human Genetics : EJHG|September 25, 2014
A clinical and genetic analysis of multiple primary cancer referrals to genetics servicesJames Whitworth, Jon Hoffman, Cyril Chapman, et al.
Breast Cancer Research and Treatment|June 21, 2013
Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancerD Gareth R Evans, Sarah L Ingham, Andrew Baildam, et al.
Journal of Medical Genetics|June 24, 2015
Lynch syndrome caused by MLH1 mutations is associated with an increased risk of breast cancer: a cohort studyElaine F Harkness, Emma Barrow, Katy Newton, et al.
Familial Cancer|June 25, 2021
Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working GroupJette J Bakhuizen, Helen Hanson, Karin van der Tuin, et al.
Pageof 17

Showing results (21-30 of 162) with videos related to

Sort By:
Pageof 17
Familial Cancer|July 20, 2007
BRCA1/2 mutation analysis in male breast cancer families from North West EnglandD G R Evans, Mike Bulman, Karen Young, et al.
Lancet (London, England)|April 4, 2003
Prediction of pathogenic mutations in patients with early-onset breast cancer by family historyFiona Lalloo, Jennifer Varley, David Ellis, et al.
Journal of Medical Genetics|February 25, 2012
Life expectancy in hereditary cancer predisposing diseases: an observational studyAnna Wilding, Sarah Louise Ingham, Fiona Lalloo, et al.
Journal of Medical Genetics|March 9, 2023
<i>MSH2</i> is the very young onset ovarian cancer predisposition gene, not <i>BRCA1</i>Nicola Flaum, Emma J Crosbie, Emma Roisin Woodward, et al.
BMC Medical Informatics and Decision Making|October 3, 2014
Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?Mattia C F Prosperi, Sarah L Ingham, Anthony Howell, et al.
Familial Cancer|March 13, 2024
Cascade screening in HBOC and Lynch syndrome: guidelines and procedures in a UK centreD Gareth Evans, Kate Green, George J Burghel, et al.
European Journal of Human Genetics : EJHG|September 25, 2014
A clinical and genetic analysis of multiple primary cancer referrals to genetics servicesJames Whitworth, Jon Hoffman, Cyril Chapman, et al.
Breast Cancer Research and Treatment|June 21, 2013
Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancerD Gareth R Evans, Sarah L Ingham, Andrew Baildam, et al.
Journal of Medical Genetics|June 24, 2015
Lynch syndrome caused by MLH1 mutations is associated with an increased risk of breast cancer: a cohort studyElaine F Harkness, Emma Barrow, Katy Newton, et al.
Familial Cancer|June 25, 2021
Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working GroupJette J Bakhuizen, Helen Hanson, Karin van der Tuin, et al.
Pageof 17